Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague
- 31 December 2006
- journal article
- Published by Elsevier in Protein Expression and Purification
- Vol. 53 (1) , 63-79
- https://doi.org/10.1016/j.pep.2006.12.018
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere deliveryVaccine, 2006
- Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in miceVaccine, 2006
- Effect of homologous and heterologous prime–boost on the immune response to recombinant plague antigensVaccine, 2005
- Design and Testing for a Nontagged F1‐V Fusion Protein as Vaccine Antigen against Bubonic and Pneumonic PlagueBiotechnology Progress, 2005
- Role of Arginine in Protein Refolding, Solubilization, and PurificationBiotechnology Progress, 2004
- Yersinia pestis (plague) vaccinesExpert Opinion on Biological Therapy, 2004
- Structure and Biogenesis of the Capsular F1 Antigen from Yersinia pestisCell, 2003
- Macromolecular organisation of recombinantYersinia pestisF1 antigen and the effect of structure on immunogenicityFEMS Immunology & Medical Microbiology, 1998
- How to measure and predict the molar absorption coefficient of a proteinProtein Science, 1995
- Effects of Fraction I from Yersinia pestis on Phagocytosis In VitroThe Journal of Infectious Diseases, 1972